Promotion of oxidative damage to arachidonic acid and α1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C
- 16 December 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 48 (12) , 2173-2179
- https://doi.org/10.1016/0006-2952(94)90351-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Drug derived radicals: mediators of the side effects of anti-inflammatory drugs?Annals of the Rheumatic Diseases, 1992
- Oxidative damage to lipids and α1-antiproteinase by phenylbutazone in the presence of haem proteins: protection by ascorbic acidBiochemical Pharmacology, 1992
- Prooxidant properties of 5-aminosalicylic acidDigestive Diseases and Sciences, 1992
- The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron-donating drugsBiochemical Journal, 1991
- The Role of Reperfusion-Induced Injury in the Pathogenesis of the Crush SyndromeNew England Journal of Medicine, 1991
- Interaction of myeloperoxidase with diclofenacBiochemical Pharmacology, 1990
- Drug Metabolism by Leukocytes and Its Role in Drug-Induced Lupus and Other Idiosyncratic Drug ReactionsCritical Reviews in Toxicology, 1990
- Apparent inactivation of α1-antiroteinase by sulphur-containing radicals derived from penicillamineBiochemical Pharmacology, 1989
- The Suppression of Iron Release from Activated Myoglobin by Physiological Electron Donors and by DesferrioxamineFree Radical Research Communications, 1989
- THE IMPORTANCE OF IRON IN RHEUMATOID DISEASEThe Lancet, 1981